{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04570267: Phase 1 Interventional Completed Healthy
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03205995: Phase 3 Interventional Recruiting Thrombotic Microangiopathies
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:actinium (<sup>225</sup> Ac) alpitatug satetraxetan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00851045: Phase 2 Interventional Completed Colorectal Cancer (CRC)
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01137006: Phase 1 Interventional Completed Malignant Melanoma
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02040844: Phase 3 Interventional Completed Cat Allergy
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02544347: Not Applicable Interventional Completed Chronic Periodontitis
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04300959: Phase 2 Interventional Unknown status Biliary Tract Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tulinercept [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02735798: Early Phase 1 Interventional Withdrawn Brain Metastases
(2016)
Source URL:
Class:
PROTEIN
